Benchmarking the Pharmaceutical Industry: A Briefing on an Irish Research Study

Nuala Calnan

doi:10.21427/ksaf-yg85

Benchmarking the Pharmaceutical Industry: A Briefing on an Irish Research Study

Nuala Calnan

Graduate Business School

Research output: Contribution to conference › Paper › peer-review

Abstract

This paper presents an Irish research study currently being undertaken by the Pharmaceutical Regulatory Science Team at the Dublin Institute of Technology (DIT) into the impact of new pharmaceutical regulatory guidance on the development and manufacture of medicinal drug products. It launches a Pharmaceutical Industry Benchmarking Questionnaire designed to assess the impact and level of implementation of the ICH Tripartite Quality Guidance Q8, Q9 and Q10.

Original language	English
DOIs	https://doi.org/10.21427/ksaf-yg85
Publication status	Published - 2011
Event	Quality Risk Management conference - Frankfurt, Germany Duration: 1 Jan 2011 → …

Conference

Conference	Quality Risk Management conference
Country/Territory	Germany
City	Frankfurt
Period	1/01/11 → …

Keywords

Pharmaceutical Regulatory Science
Pharmaceutical Industry Benchmarking Questionnaire
ICH Tripartite Quality Guidance Q8
Q9
Q10

Access to Document

10.21427/ksaf-yg85Licence: CC BY-NC-SA

Cite this

@conference{e0db17b3ccba4484bbbf51a60f41f056,

title = "Benchmarking the Pharmaceutical Industry: A Briefing on an Irish Research Study",

abstract = "This paper presents an Irish research study currently being undertaken by the Pharmaceutical Regulatory Science Team at the Dublin Institute of Technology (DIT) into the impact of new pharmaceutical regulatory guidance on the development and manufacture of medicinal drug products. It launches a Pharmaceutical Industry Benchmarking Questionnaire designed to assess the impact and level of implementation of the ICH Tripartite Quality Guidance Q8, Q9 and Q10.",

keywords = "Pharmaceutical Regulatory Science, Pharmaceutical Industry Benchmarking Questionnaire, ICH Tripartite Quality Guidance Q8, Q9, Q10",

author = "Nuala Calnan",

year = "2011",

doi = "10.21427/ksaf-yg85",

language = "English",

note = "Quality Risk Management conference ; Conference date: 01-01-2011",

}

TY - CONF

T1 - Benchmarking the Pharmaceutical Industry: A Briefing on an Irish Research Study

AU - Calnan, Nuala

PY - 2011

Y1 - 2011

N2 - This paper presents an Irish research study currently being undertaken by the Pharmaceutical Regulatory Science Team at the Dublin Institute of Technology (DIT) into the impact of new pharmaceutical regulatory guidance on the development and manufacture of medicinal drug products. It launches a Pharmaceutical Industry Benchmarking Questionnaire designed to assess the impact and level of implementation of the ICH Tripartite Quality Guidance Q8, Q9 and Q10.

AB - This paper presents an Irish research study currently being undertaken by the Pharmaceutical Regulatory Science Team at the Dublin Institute of Technology (DIT) into the impact of new pharmaceutical regulatory guidance on the development and manufacture of medicinal drug products. It launches a Pharmaceutical Industry Benchmarking Questionnaire designed to assess the impact and level of implementation of the ICH Tripartite Quality Guidance Q8, Q9 and Q10.

KW - Pharmaceutical Regulatory Science

KW - Pharmaceutical Industry Benchmarking Questionnaire

KW - ICH Tripartite Quality Guidance Q8

KW - Q9

KW - Q10

U2 - 10.21427/ksaf-yg85

DO - 10.21427/ksaf-yg85

M3 - Paper

T2 - Quality Risk Management conference

Y2 - 1 January 2011

ER -